| Literature DB >> 28728983 |
Simon L Currie1, Jedediah J Doane1, Kathryn S Evans1, Niraja Bhachech1, Bethany J Madison1, Desmond K W Lau2, Lawrence P McIntosh2, Jack J Skalicky3, Kathleen A Clark1, Barbara J Graves4.
Abstract
The recruitment of transcriptional cofactors by sequence-specific transcription factors challenges the basis of high affinity and selective interactions. Extending previous studies that the N-terminal activation domain (AD) of ETV5 interacts with Mediator subunit 25 (MED25), we establish that similar, aromatic-rich motifs located both in the AD and in the DNA-binding domain (DBD) of the related ETS factor ETV4 interact with MED25. These ETV4 regions bind MED25 independently, display distinct kinetics, and combine to contribute to a high-affinity interaction of full-length ETV4 with MED25. High-affinity interactions with MED25 are specific for the ETV1/4/5 subfamily as other ETS factors display weaker binding. The AD binds to a single site on MED25 and the DBD interacts with three MED25 sites, allowing for simultaneous binding of both domains in full-length ETV4. MED25 also stimulates the in vitro DNA binding activity of ETV4 by relieving autoinhibition. ETV1/4/5 factors are often overexpressed in prostate cancer and genome-wide studies in a prostate cancer cell line indicate that ETV4 and MED25 occupy enhancers that are enriched for ETS-binding sequences and are both functionally important for the transcription of genes regulated by these enhancers. AP1-motifs, which bind JUN and FOS transcription factor families, were observed in MED25-occupied regions and JUN/FOS also contact MED25; FOS strongly binds to the same MED25 site as ETV4 AD and JUN interacts with the other two MED25 sites. In summary, we describe features of the multivalent ETV4- and AP1-MED25 interactions, thereby implicating these factors in the recruitment of MED25 to transcriptional control elements.Entities:
Keywords: ETS transcription factors; JUN/FOS.; Mediator complex.; Prostate cancer.
Mesh:
Substances:
Year: 2017 PMID: 28728983 PMCID: PMC5632138 DOI: 10.1016/j.jmb.2017.06.024
Source DB: PubMed Journal: J Mol Biol ISSN: 0022-2836 Impact factor: 5.469